MedTrace Logo

Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection

NCT06377462 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-05-15

No results posted yet for this study

Summary

The aim is rapid collection of real-life data on the epidemiology, treatment and disease course in patients with VEXAS syndrome during routine clinical practice and collect biomaterials to evaluate genotype-phenotype associations, determine optimal treatment schedule, identify diagnostic features and biomarkers

Conditions

  • VEXAS Syndrome

Sponsors & Collaborators

  • Bristol-Myers Squibb

    collaborator INDUSTRY

  • University Hospital Munich

    collaborator OTHER

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Katja Sockel, Dr. med. · TU Dresden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-13
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06377462 on ClinicalTrials.gov